Glaucoma is the second most common cause of blindness in the UK and the USA. Up to 2 per cent of the population have glaucoma, and only about half of these are aware that they have this eye disease. The most prevalent form of glaucoma is called primary open-angle glaucoma, accounting for 60 to 70 per cent of all glaucomas.

Generally there are no early symptoms. By the time that visual field loss is noticed, some of the optic nerves have already been destroyed and cannot be regenerated. Nearly always the start of glaucoma can be diagnosed by a rise in pressure of the fluid in the eye. Routine annual eye examinations are recommended for persons over 40 years so that glaucoma can be detected and treated as early as possible. Those who are more vunerable such as diabetics may need more frequent eye examination. Any sudden loss of any part of vision or any eye pain should be considered a medical emergency requiring immediate attention from a qualified practitioner.

The tonicity of the fluid within the eye is maintained within narrow limits by the addition and subtraction of sodium chloride. In a healthy eye this tonicity provides the right level of sodium chloride for the effectiveness of the anti-microbial peptides within the eye. Salty fluid in the front chamber of the eye normally drains from the eye through a sponge filled gap between the iris and the cornea. If the salty fluid is not of the correct tonicity, commonly occuring in persons with hypertension or diabetes, then the anti-microbial peptides become ineffective. As a result common skin microbes can enter the channels in the spongy material and the eye fluid drain becomes blocked.

Thus the internal pressure of the eye rises, causing the destruction of tiny blood vessels at the back of the eye where nerve fibres from the retina enter the optic nerve. This is the outcome of untreated open-angle glaucoma, which usually affects both eyes equally.

Another cause of optic nerve damage is the result of miliaria of the head causing subtle interruptions in blood supply to the eyes, similar to the interruptions to the supply to the brain in migraine. In fact, these two miliaria class conditions, causing eye pain and headache, may occur together.

Another chronic eye condition, dry eye conjunctivitis, is also a miliaria class condition. The conjunctiva are the mucus membrane of the eye itself, and of the inner surface of the eyelids. The constant presence of salty mucus is necessary to lubricate the movement of the eye and to provide protection against common skin microbes and airborne particles. This liquid is supplemented by salty tears from the lachrymal glands located one above each eye. The tears flow from the glands down between six and twelve ducts which pour the liquid onto the front of the upper eye.

These ducts are havards and behave similarly to sweat gland ducts. Normally a very small insensible amount of liquid spreads onto the eye and is then carried away into the nose. At times of distress or emotion, or if the eye is irritated, there is a copious flow of tears which spills out of the eye onto the face. If there is frequent stimulation of the lachrymal ducts, and also the mucus ducts of the eye, then the ducts become habituated to the faster movement of fluid and reabsorb excess sodium. This affects the tonicity of the fluid and, as a result the anti-microbial peptides become ineffective. Common skin microbes can then enter the ducts and the immune reaction to their presence blocks the ducts.

This is the cause of dry eye conjunctivitis.

Treatment of the above eye conditions needs to be aimed at restoring the proper sodium balance and at the same time treating essential hypertension, which affects the eyes. This can be done very effectively with ActivSignal^TM Sodium, a new invention of Warren Ward. This medication signals to the body that there is sufficient sodium in the body environment, the ducts stop over-conserving sodium and salinity rises to allow anti-microbial peptides to unblock the ducts. As with other miliaria class diseases, blood glucose needs to be kept down to the normal original habituation level for the individual.

Persons with myopia and essential hypertension are likely to find that if their hypertension is treated with ActivSignal^TM Sodium, then their myopia may be considerably reduced after a period of blood pressure below the optimum level of 120 over 80.

ActivSignal^TM therapeutic products are not absorbed into the body and have no side effects. The first commercial ActivSignal product is now under development.